Skip to main content
. 2004 Jun;72(6):3359–3365. doi: 10.1128/IAI.72.6.3359-3365.2004

TABLE 2.

Phenotypic characteristics of strains recovered from the brainc

Strain Doubling time (h) Capsule thickness (μm)b MIC of drug for straina
Capsule structure
ITZ FCZ AmB Fluorescence intensity (MdF) Heterogeneity of cell population (CVF)
B.1.1 5.0 0.17 ± 0.05 0.5 8 1 1.2 202
B.1.2 4.2 0.20 ± 0.10 0.5 8 0.5 31.7 203
B.1.3 4.1 0.16 ± 0.06 0.25 8 0.5 79.6 144
B.1.4 3.9 0.16 ± 0.05 0.5 4 0.5 9.7 227
B.1.5 3.7 0.23 ± 0.09 0.125 4 0.5 70.2 163
B.8.1 4.0 0.20 ± 0.08 0.5 8 1 34.4 200
B.8.2 4.1 0.17 ± 0.05 0.25 8 0.5 86.4 143
B.8.3 4.1 0.20 ± 0.06 0.125 8 0.5 13.3 247
B.8.4 3.7 0.17 ± 0.06 0.25 8 0.5 17.4 209
B.8.5 4.2 0.19 ± 0.05 0.06 4 0.5 43.7 162
B.35.1 6.1 0.17 ± 0.04 0.03 4 0.5 5.4 250
B.35.2 6.6 0.16 ± 0.05 0.03 2 0.5 8.7 235
B.35.3 7.1 0.16 ± 0.06 0.03 4 0.5 7.0 232
B.35.4 3.9 0.23 ± 0.06 0.125 8 0.5 14.7 224
B.35.5 19.6 0.17 ± 0.05 0.015 2 0.25 8.0 249
a

ITZ, itraconazole; FCZ, fluconazole; AmB, amphotericin B.

b

Data are means ± SD.

c

Different phenotypes of strains recovered from the brain on day 1 (B.1.X), day 8 (B.8.X), and day 35 (B.35.X) were studied.